Happiness Biotech Group Limited (NASDAQ:HAPP) has earned an average broker rating score of 1.00 (Strong Buy) from the one brokers that cover the company, Zacks Investment Research reports. One investment analyst has rated the stock with a strong buy rating.
Brokers have set a 1 year consensus price objective of $10.50 for the company, according to Zacks. Zacks has also given Happiness Biotech Group an industry rank of 50 out of 255 based on the ratings given to related companies.
Separately, Aegis assumed coverage on shares of Happiness Biotech Group in a research note on Friday, December 6th. They issued a “buy” rating on the stock.
Happiness Biotech Group Company Profile
Happiness Biotech Group Limited engages in the research, development, manufacture, and sale of nutraceutical and dietary supplements products made of Lucidum spore powder and others in the People's Republic of China. It also offers edible fungi. The company was founded in 2004 and is based in Nanping, the People's Republic of China.
Read More: How to invest using market indexes
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Happiness Biotech Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Happiness Biotech Group and related companies with MarketBeat.com's FREE daily email newsletter.